Delivery Order SPE2DB22D1103-SPE2DB25FH3D9
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,136.93 to AmerisourceBergen Drug Corp for the supply of Doxycycline Monohydrate 100 mg capsules in unit-dose packaging of 30 tablets. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded and completed on July 24, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical supply arrangement. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $4,884.22 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg capsules (500-count units). This competitively awarded, firm fixed-price delivery order was issued on August 22, 2025, with an ultimate completion date of August 25, 2025. The contract carries no set-aside designation, and the place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,000.28 to AmerisourceBergen Drug Corp for Doxycycline Hyclate 50 mg capsules (500-count supply) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, non-set-aside contract employs firm fixed-price pricing and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Doxycycline IR-DR 40 mg capsules (30-count) with a contract value of $3,077.22. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and no set-aside designation was utilized. The order will be performed in Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Doxycycline Mono 100 mg capsules in unit dose packs of 50 units, with a contract ceiling value of $1,055.60. This delivery order, classified as a firm fixed price contract with no set-aside designation, represents a competitive award for pharmaceutical supplies to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $10,374.00 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg tablets (300 count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded contract utilizes firm fixed pricing with no set-aside designation. The pharmaceutical product will be delivered to the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate office. This...
- The Defense Logistics Agency awarded a $1,199.28 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units. This is a firm fixed-price, non-set-aside contract with a completion date of September 11, 2025, and performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's significant role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, with a ceiling value of $3,906.59 and a completion date of September 23, 2025. This non-set-aside contract reflects a firm fixed price arrangement for pharmaceutical delivery to support federal medical supply needs. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Doxycycline 50 mg, with a ceiling value of $2,358.72 and an ultimate completion date of September 26, 2025. This award represents a competitive, firm fixed-price delivery order with no set-aside designation, reflecting the agency's selection of AmerisourceBergen based on open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen's...
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,568,173,863 units of doxycycline monohydrate 100 mg capsules. The $4,487.10 firm fixed-price delivery order has a performance period through May 8, 2025 and is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH3D9Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Doxycycline Monohydrate 100 mg capsules (250-count units) valued at $1,571.53 with a firm fixed price structure. The order, issued on September 24, 2025, represents a non-competitive set-aside award and is scheduled for completion by September 25, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery, which supports the federal medical procurement needs of military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 prime vehicle running through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's established role as a major pharmaceutical distributor and federal vendor demonstrates its capacity to fulfill this antibiotic supply requirement as part of its extensive portfolio serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/24/25 |